Webinar: Advancing Lung Cancer ScreeningFrom clinical research to nationwide programs
Every year, World Lung Cancer Day is observed on August 1, to create awareness and educate people worldwide about the concerning issues of lung cancer and to advocate for a stronger focus on lung cancer research to enable early detection and treatment of this disease.
To support this initiative on World Lung Cancer Day, Siemens Healthineers will be inviting a diverse assembly of key stakeholders from various sectors to share their valuable research findings, insights, and advocacy efforts related to advancing lung cancer screening. It will also provide a unique opportunity for attendees to gain exposure to global perspectives and learn about best practices in the field, fostering a collaborative environment aimed at raising awareness and enhancing lung cancer screening initiatives.
Topics
The webinar series will span two days, with the first day dedicated to discussions on detection and the second day concentrating on surgery and therapy.
Date: August 1 - 2, 2024
Time: 6:00 - 7:30 p.m. Singapore | Kuala Lumpur | Philippines Time (GMT +8)
Dr. Sewanti Limaye
Topic - Perspective: APAC coalition against lung cancer
Dr. Sewanti Limaye is the Director of Medical & Precision Oncology at Sir H. N. Reliance Foundation Hospital in Mumbai, India, where she pioneered the country's first Precision Oncology clinic and advanced oncology research. With prior roles at Columbia University and Dana Farber Cancer Institute, she specializes in solid tumors and has a strong research background, including a Masters in Cancer Genomics. Dr. Limaye has led international trials, co-founded Iylon Precision Oncology, and received numerous awards. She is currently focused on enhancing Cancer Care and Precision Oncology at Sir H. N. Reliance Foundation Hospital.
Natthaya Triphuridet, MD, PhD
Topic - Clinician's voice: Integrative Lung Cancer Screening in Thailand
Dr. Natthaya Triphuridet is a pulmonologist and instructor at Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy in Bangkok, Thailand. She earned her MD from Khon Kaen University and a PhD in Clinical Epidemiology from Thammasat University. Dr. Triphuridet completed post-doctoral training in lung cancer screening at the Icahn School of Medicine at Mount Sinai. With significant experience as a principal investigator in integrative lung cancer screening, she has received multiple awards for her research and has served on the IASLC screening and early detection committee. Dr. Triphuridet is also widely published in leading medical journals.
Mr. Norman Ng
Topic - Perspective: Lung cancer patient concern group
Mr. Norman Ng, convener of the Lung Cancer Patient Concern Group in Hong Kong, will share his journey as a lung cancer patient, underscoring the need for comprehensive support from diagnosis to treatment and beyond. His belief in this necessity led to the establishment of the new Lung Cancer Patient Concern Group, dedicated to advocating for improved screening methods using low-dose CT, biomarkers, diagnostics, treatment options, and psychosocial care. The group's mission reaffirms the importance of comprehensive care for lung cancer patients.
Dr Choo Bok Ai
Topic - Cancer treatment and care - a radiation oncologist's perspective
Dr. Choo Bok Ai is a Radiation Oncologist with over 20 years of experience in cancer care. He graduated from the University of Aberdeen in 1998 and obtained his postgraduate internal medicine training qualification from the Royal College of Physicians in London in 2002. Completing his clinical oncology specialist training in 2007 in Birmingham, Dr. Choo is a Fellow of the UK Royal College of Radiologists and the Academy of Medicine Singapore. He is currently the Chairman of the Chapter of Radiation Oncology. Dr. Choo’s practice includes advanced radiation therapy technologies and the treatment of various cancers. He has been a principal investigator in multiple clinical trials, published over 30 peer-reviewed articles, and received numerous awards, including the Singapore Patient Advocate Award and the Healthcare Humanity Award.
Dr. Edmund E. Villaroman
Topic - A surgeon's perspective on lung cancer in the Philippines
Dr. Edmund E. Villaroman is a Cardiothoracic Surgeon specializing in Interventional Bronchoscopy, Minimally Invasive Thoracic Surgery, and Robotic Thoracic Surgery. He completed his MD and residency at the University of Santo Tomas and fellowship at the Lung Center of the Philippines. As Chairman of the Department of Thoracic Surgery at the Lung Center of the Philippines and Secretary-General of the SEATS School of Thoracic Surgery, he pioneered minimally invasive thoracic surgery in the Philippines, performing over 250 VATS lobectomies. He is a faculty member of the ASEAN VATS study group, a founding member of the Southeast Asian Thoracic Surgery Society, and a past president of the Philippine Association of Thoracic Cardiac & Vascular Surgery Inc.
Ms. Judy Li
Topic - Bridging the Gap: Enhancing Lung Cancer Care and Access in ASEAN - Insights from the APAC White Paper
Judy is the Manager for ASPIRE (Asia Pacific Policy Review and Engagement) for Lung Cancer. With a strong background in healthcare policy and advocacy, Judy leads ASPIRE's efforts to improve lung cancer care and access across the Asia-Pacific region. She also co-authored the white paper being presented, bringing her extensive experience and insights to the project. Her expertise in coordinating multi-stakeholder initiatives and driving policy reforms has been instrumental in advancing ASPIRE's mission. Judy's dedication to fostering collaboration and her in-depth knowledge of regional health systems make her a key figure in the fight against lung cancer in APAC.
Register here
Past webinars
Lung screening – from clinical studies to established programs
In this video recording, the panel of experts share their insights and perspectives on the current status of lung cancer screening, including the latest advancements in technology, best practices for patient selection, and ongoing research efforts.